TWiV 764: COVID-19 clinical update #65 with Dr. Daniel Griffin
Jun 05, 2021•40 min•Ep. 764
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #65, Daniel Griffin summarizes effects of non-pharmaceutical interventions, updated summer camp guidance from CDC, serology testing not recommended by FDA, antigen tests during a music event, inhibition of vaccine immunogenicity by methotrexate, phase 3 trial results for colchicine, and small airway disease as a post-acute sequelae.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Effects of vaccines and NPIs (JAMA)
- Guidance on summer camps (CDC)
- Antibody testing not recommended (FDA)
- Antigen testing at a music event (Lancet)
- Methotrexate and vaccine immunogenicity (Ann Rheum Dis)
- Colchicine phase 3 results (Lancet Resp Med)
- Small airway disease a post-acute sequelae (medRxiv)
- Letters read on TWiV 764
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android